Mortality and Causes of Death in Patients With Osteogenesis Imperfecta

A Register-Based Nationwide Cohort Study

Lars Folkestad, Jannie Dahl Hald, Vladimir Canudas-Romo, Jeppe Gram, Anne Pernille Hermann, Bente Langdahl, Bo Abrahamsen, Kim Brixen

Research output: Contribution to journalArticle

Abstract

Osteogenesis imperfecta (OI) is a hereditary connective tissue disease that causes frequent fractures. Little is known about causes of death and length of survival in OI. The objective of this work was to calculate the risk and cause of death, and the median survival time in patients with OI. This study was a Danish nationwide, population-based and register-based cohort study. We used National Patient Register data from 1977 until 2013 with complete long-term follow-up. Participants comprised all patients registered with the diagnosis of OI from 1977 until 2013, and a reference population matched five to one to the OI cohort. We calculated hazard ratios for all-cause mortality and subhazard ratios for cause-specific mortality in a comparison of the OI cohort and the reference population. We also calculated all-cause mortality hazard ratios for males, females, and age groups (0 to 17.99 years, 18.00 to 34.99 years, 35.00 to 54.99 years, 55.00 to 74.99 years, and >75 years). We identified 687 cases of OI (379 women) and included 3435 reference persons (1895 women). A total of 112 patients with OI and 257 persons in the reference population died during the observation period. The all-cause mortality hazard ratio between the OI cohort and the reference population was 2.90. The median survival time for males with OI was 72.4 years, compared to 81.9 in the reference population. The median survival time for females with OI was 77.4 years, compared to 84.5 years in the reference population. Patients with OI had a higher risk of death from respiratory diseases, gastrointestinal diseases, and trauma. We were limited by the lack of clinical information about phenotype and genotype of the included patients. Patients with OI had a higher mortality rate throughout their life compared to the general population.

Original languageEnglish (US)
Pages (from-to)2159-2166
Number of pages8
JournalJournal of Bone and Mineral Research
Volume31
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Osteogenesis Imperfecta
Cause of Death
Cohort Studies
Mortality
Population
Survival
Connective Tissue Diseases
Gastrointestinal Diseases
Registries

Keywords

  • CAUSES OF DEATH
  • COLLAGEN DEFECTS
  • OSTEOGENESIS IMPERFECTA
  • RARE BONE DISORDERS
  • REGISTER-BASED RESEARCH

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Folkestad, L., Hald, J. D., Canudas-Romo, V., Gram, J., Hermann, A. P., Langdahl, B., ... Brixen, K. (2016). Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study. Journal of Bone and Mineral Research, 31(12), 2159-2166. https://doi.org/10.1002/jbmr.2895

Mortality and Causes of Death in Patients With Osteogenesis Imperfecta : A Register-Based Nationwide Cohort Study. / Folkestad, Lars; Hald, Jannie Dahl; Canudas-Romo, Vladimir; Gram, Jeppe; Hermann, Anne Pernille; Langdahl, Bente; Abrahamsen, Bo; Brixen, Kim.

In: Journal of Bone and Mineral Research, Vol. 31, No. 12, 01.12.2016, p. 2159-2166.

Research output: Contribution to journalArticle

Folkestad, L, Hald, JD, Canudas-Romo, V, Gram, J, Hermann, AP, Langdahl, B, Abrahamsen, B & Brixen, K 2016, 'Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study', Journal of Bone and Mineral Research, vol. 31, no. 12, pp. 2159-2166. https://doi.org/10.1002/jbmr.2895
Folkestad, Lars ; Hald, Jannie Dahl ; Canudas-Romo, Vladimir ; Gram, Jeppe ; Hermann, Anne Pernille ; Langdahl, Bente ; Abrahamsen, Bo ; Brixen, Kim. / Mortality and Causes of Death in Patients With Osteogenesis Imperfecta : A Register-Based Nationwide Cohort Study. In: Journal of Bone and Mineral Research. 2016 ; Vol. 31, No. 12. pp. 2159-2166.
@article{31a4d64e21054e029eb95f73de4c4100,
title = "Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study",
abstract = "Osteogenesis imperfecta (OI) is a hereditary connective tissue disease that causes frequent fractures. Little is known about causes of death and length of survival in OI. The objective of this work was to calculate the risk and cause of death, and the median survival time in patients with OI. This study was a Danish nationwide, population-based and register-based cohort study. We used National Patient Register data from 1977 until 2013 with complete long-term follow-up. Participants comprised all patients registered with the diagnosis of OI from 1977 until 2013, and a reference population matched five to one to the OI cohort. We calculated hazard ratios for all-cause mortality and subhazard ratios for cause-specific mortality in a comparison of the OI cohort and the reference population. We also calculated all-cause mortality hazard ratios for males, females, and age groups (0 to 17.99 years, 18.00 to 34.99 years, 35.00 to 54.99 years, 55.00 to 74.99 years, and >75 years). We identified 687 cases of OI (379 women) and included 3435 reference persons (1895 women). A total of 112 patients with OI and 257 persons in the reference population died during the observation period. The all-cause mortality hazard ratio between the OI cohort and the reference population was 2.90. The median survival time for males with OI was 72.4 years, compared to 81.9 in the reference population. The median survival time for females with OI was 77.4 years, compared to 84.5 years in the reference population. Patients with OI had a higher risk of death from respiratory diseases, gastrointestinal diseases, and trauma. We were limited by the lack of clinical information about phenotype and genotype of the included patients. Patients with OI had a higher mortality rate throughout their life compared to the general population.",
keywords = "CAUSES OF DEATH, COLLAGEN DEFECTS, OSTEOGENESIS IMPERFECTA, RARE BONE DISORDERS, REGISTER-BASED RESEARCH",
author = "Lars Folkestad and Hald, {Jannie Dahl} and Vladimir Canudas-Romo and Jeppe Gram and Hermann, {Anne Pernille} and Bente Langdahl and Bo Abrahamsen and Kim Brixen",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/jbmr.2895",
language = "English (US)",
volume = "31",
pages = "2159--2166",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Mortality and Causes of Death in Patients With Osteogenesis Imperfecta

T2 - A Register-Based Nationwide Cohort Study

AU - Folkestad, Lars

AU - Hald, Jannie Dahl

AU - Canudas-Romo, Vladimir

AU - Gram, Jeppe

AU - Hermann, Anne Pernille

AU - Langdahl, Bente

AU - Abrahamsen, Bo

AU - Brixen, Kim

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Osteogenesis imperfecta (OI) is a hereditary connective tissue disease that causes frequent fractures. Little is known about causes of death and length of survival in OI. The objective of this work was to calculate the risk and cause of death, and the median survival time in patients with OI. This study was a Danish nationwide, population-based and register-based cohort study. We used National Patient Register data from 1977 until 2013 with complete long-term follow-up. Participants comprised all patients registered with the diagnosis of OI from 1977 until 2013, and a reference population matched five to one to the OI cohort. We calculated hazard ratios for all-cause mortality and subhazard ratios for cause-specific mortality in a comparison of the OI cohort and the reference population. We also calculated all-cause mortality hazard ratios for males, females, and age groups (0 to 17.99 years, 18.00 to 34.99 years, 35.00 to 54.99 years, 55.00 to 74.99 years, and >75 years). We identified 687 cases of OI (379 women) and included 3435 reference persons (1895 women). A total of 112 patients with OI and 257 persons in the reference population died during the observation period. The all-cause mortality hazard ratio between the OI cohort and the reference population was 2.90. The median survival time for males with OI was 72.4 years, compared to 81.9 in the reference population. The median survival time for females with OI was 77.4 years, compared to 84.5 years in the reference population. Patients with OI had a higher risk of death from respiratory diseases, gastrointestinal diseases, and trauma. We were limited by the lack of clinical information about phenotype and genotype of the included patients. Patients with OI had a higher mortality rate throughout their life compared to the general population.

AB - Osteogenesis imperfecta (OI) is a hereditary connective tissue disease that causes frequent fractures. Little is known about causes of death and length of survival in OI. The objective of this work was to calculate the risk and cause of death, and the median survival time in patients with OI. This study was a Danish nationwide, population-based and register-based cohort study. We used National Patient Register data from 1977 until 2013 with complete long-term follow-up. Participants comprised all patients registered with the diagnosis of OI from 1977 until 2013, and a reference population matched five to one to the OI cohort. We calculated hazard ratios for all-cause mortality and subhazard ratios for cause-specific mortality in a comparison of the OI cohort and the reference population. We also calculated all-cause mortality hazard ratios for males, females, and age groups (0 to 17.99 years, 18.00 to 34.99 years, 35.00 to 54.99 years, 55.00 to 74.99 years, and >75 years). We identified 687 cases of OI (379 women) and included 3435 reference persons (1895 women). A total of 112 patients with OI and 257 persons in the reference population died during the observation period. The all-cause mortality hazard ratio between the OI cohort and the reference population was 2.90. The median survival time for males with OI was 72.4 years, compared to 81.9 in the reference population. The median survival time for females with OI was 77.4 years, compared to 84.5 years in the reference population. Patients with OI had a higher risk of death from respiratory diseases, gastrointestinal diseases, and trauma. We were limited by the lack of clinical information about phenotype and genotype of the included patients. Patients with OI had a higher mortality rate throughout their life compared to the general population.

KW - CAUSES OF DEATH

KW - COLLAGEN DEFECTS

KW - OSTEOGENESIS IMPERFECTA

KW - RARE BONE DISORDERS

KW - REGISTER-BASED RESEARCH

UR - http://www.scopus.com/inward/record.url?scp=84994182494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994182494&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2895

DO - 10.1002/jbmr.2895

M3 - Article

VL - 31

SP - 2159

EP - 2166

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 12

ER -